Ctively). The Fc of those antibodies was engineered to consist of the triple mutation N297G/S298G/T299A
Ctively). The Fc of those antibodies was engineered to consist of the triple mutation N297G/S298G/T299A that eliminates glycosylation as well as the binding to FcR and to the complement method…